FDA Inspection 811362 — Eurofins Biopharma Product Testing, Denmark A/S

Eurofins Biopharma Product Testing, Denmark A/S — FEI 3006272083

The FDA completed an inspection of Eurofins Biopharma Product Testing, Denmark A/S on Dec 14, 2012 in Glostrup. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 14, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Glostrup (Denmark)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.